Physician profile
Michael T Rossidis
NPI 1477909786
$6,548.93
in general payments reported to CMS, 2019-2025
20 companies · $2,386 in 2025
The $2,386 reported for 2025 was more than what 86% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.25 · 2020: $317 · 2021: $741 · 2022: $2,155 · 2023: $143 · 2024: $776 · 2025: $2,386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,755 · Food and Beverage: $1,550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,755.27 |
| Food and Beverage | $1,549.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Goode Surgical INC | $2,842.96 | 2022-2025 | |
| Arthrex, INC. | $1,136.48 | 2025 | |
| Stryker Corporation | $871.85 | 2020-2022 | |
| Treace Medical Concepts, INC. | $396.51 | 2021-2024 | |
| Paratek Pharmaceuticals, INC. | $243.30 | 2021-2025 | Nuzyra |
| In2bones USA, LLC | $208.99 | 2021-2022 | |
| Smith+Nephew, INC. | $203.41 | 2019-2024 | Collagenase Santyl, Regranex |
| Acera Surgical, INC. | $129.74 | 2023 | Restrata Wound Matrix |
| Zimmer Biomet Holdings, INC. | $109.25 | 2021-2022 | |
| Integra Lifesciences Corporation | $93.63 | 2021-2022 | |
| Avita Medical Americas, LLC | $78.10 | 2025 | Permeaderm, Recell, Cohealyx |
| Orthofix Medical, INC. | $41.27 | 2024 | Physio-Stim |
| Forte Bio-Pharma LLC | $40.70 | 2025 | Prolate, Tanlor, Nalocet |
| Ethicon US, LLC | $35.90 | 2025 | Vistaseal, Ethicon |
| Amgen INC. | $25.52 | 2024 | Krystexxa |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Misonix INC | $22.43 | 2020-2021 | |
| Reapplix INC. | $19.40 | 2022 | |
| Bioventus LLC | $17.22 | 2021 | |
| Kci USA, INC. | $17.07 | 2021 | |
| Paragon 28, INC. | $15.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Rossidis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.